Skip to main content
OpenTrials
Completed

NCT Number: NCT05339542

Platelet Rich Plasma in Plantar Fasciitis

a number of patient diagnosed as degenerative plantar fasciitis will be collected and divided into two groups, group I will be injected by platelet rich plasma and group II will be injected methylprednisolone

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Plantar Fascitis

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Minya university

Minya, Egypt

About this study

the study will include 100 patients diagnosed as degenerative plantar fasciitis and will be evaluated by musculoskeletal ultrasound by two observes and the will divided randomly into two groups who will be injected under ultrasound imaging by either Platelet rich plasma or methylprednisolone. selection of patient will be randomly and the study will be double blinded.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Clinical diagnosis of plantar fasciitis

Exclusion criteria

(history or current):

  • Rheumatic diseases
  • Foot Trauma
  • Neurological diseases
  • Thyroid disease
  • Diabetes mellitus
  • Chronic Renal Failure

Treatment and study plan

Platelet Rich Plasma

Other

derived from patient own blood

Methylprednisolone 40 mg

Drug

active comparative intervention

Other names: 1 ml Lidocaine 2%

Primary outcomes

  1. visual analogue scale

    Time frame: 3 months

    visual analogue scale from 0-10, where 0 denoting maximum pain relief and 10 denoting no pain relief

  2. Manchester-Oxford Foot Questionnaire

    Time frame: 3 months

    the Manchester-Oxford Foot Questionnaire is a 16-item instrument answered on a five-point Likert scale (each item is scored from 0 to 4, with 4 denoting 'most severe'). Scores for each item are summed to form three separate sub scales representing underlying domains: walking/standing problems (seven items), foot pain (five items), and issues related to social interaction (four items)

Secondary outcomes

  1. echogenicity in longitudinal scan gray scale ultrasound

    Time frame: 3 months

    Hypoechogenicity was defined as a lack of the homogeneous fibrillar pattern with loss of the tightly packed echogenic lines after correcting for anisotropy. increased echogenicity is consistent with plantar fasciitis

  2. plantar fascia thickness at the insertion in longitudinal scan of the heel

    Time frame: 3 months

    measurement of plantar fascia thickness at the insertion in longitudinal view of the heel. Normal thickness is ≤ 4mm. increased thickness is consistent with plantar fasciitis

Sponsors and collaborators

Lead sponsor

Minia University

Other

Registry information

Official study title

Musculoskeletal Ultrasound Changes in the Plantar Fascia After a Single Injection of Platelet Rich Plasma Compared to Steroid

Acronym: PRP

Important dates

Study start
2022
Primary completion
2022
Study completion
2022
First posted
Apr 21, 2022
Registry last updated
Jul 6, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.